Abstract:Emerging evidence suggests that physiological C-terminal truncation of α-synuclein (αS) plays a critical role in regulating liquid-liquid phase separation and promoting amyloid aggregation, processes implicated in neurodegenerative diseases such as Parkinson's disease (PD). However, the molecular mechanisms through which C-terminal truncation influences αS conformation and modulates its aggregation remain poorly understood. In this study, we investigated the impact of C-terminal truncation on αS conformational dynamics by comparing full-length αS1-140 with truncated αS1-103 monomers using atomistic discrete molecular dynamics simulations. Our findings revealed that both αS1-140 and αS1-103 primarily adopted helical conformations around residues 7-32, while residues 36-95, located in the second half of the N-terminal and NAC domains, predominantly formed a dynamic β-sheet core. The C-terminus of αS1-140 was largely unstructured and dynamically wrapped around the β-sheet core. While residues 1-95 exhibited similar secondary structure propensities in both αS1-140 and αS1-103, the dynamic capping by the C-terminus in αS1-140 slightly enhanced β-sheet formation around residues 36-95. In contrast, key aggregation-driving regions (residues 2-9, 36-42, 45-57, and 68-78) were dynamically shielded by the C-terminus in αS1-140, reducing their exposure and potentially preventing interpeptide interactions that drive aggregation. C-terminal truncation, on the other hand, increased the exposed surface area of these aggregation-prone regions, thereby enhancing interpeptide interactions, phase separation, and amyloid aggregation. Overall, our simulations provide valuable insights into the conformational effects of C-terminal truncation on αS and its role in promoting pathological aggregation.

-Synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations

Exploring the Impact of Physiological C-Terminal Truncation on Α-Synuclein Conformations to Unveil Mechanisms Regulating Pathological Aggregation

β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein

Divergent effects of pathological α-synuclein truncations and mutations on phase separation

Distinct Effects of Familial Parkinson's Disease-Associated Mutations on Α-Synuclein Phase Separation and Amyloid Aggregation.

Aggregation and phase separation of α-synuclein in Parkinson's disease

C-terminal Truncation Exacerbates the Aggregation and Cytotoxicity of Α-Synuclein: A Vicious Cycle in Parkinson's Disease.

Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations

The N-terminal Region of alpha-Synuclein Controls Amyloid Nucleation at the Condensate Interface

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis

C-terminal truncation of α -synuclein alters DNA structure from extension to compaction

SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation

Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation

Liquid-liquid phase separation and liquid-to-solid transition mediate α-synuclein amyloid fibril containing hydrogel formation

Liquid–liquid phase separation and conformational strains of α-Synuclein: implications for Parkinson's disease pathogenesis

Altered Conformation of Α-Synuclein Drives Dysfunction of Synaptic Vesicles in a Synaptosomal Model of Parkinson's Disease.

α-Synuclein Oligomers Displace Monomeric α-Synuclein from Lipid Membranes

Self-limiting multimerization of α-synuclein on membrane and its implication in Parkinson's diseases

Author Correction: Post-translational Modifications of Soluble Α-Synuclein Regulate the Amplification of Pathological Α-Synuclein

Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease

Role of Different Regions of Alpha-Synuclein in the Assembly of Fibrils